Literature DB >> 17523337

Survival analysis after surgical treatment of gastric cancer: review of 121 cases.

Okay Nazli1, Hayrullah Derici, Tugrul Tansug, Ismail Yaman, Ali Dogan Bozdag, Ali Serdar Isgüder, Hakan Bölükbasi.   

Abstract

BACKGROUND/AIMS: This study was performed to evaluate major morbidity, early mortality and to analyze survival in our patients that underwent surgical treatment for gastric cancer.
METHODOLOGY: Records of 121 patients with gastric adenocarcinoma that underwent surgery between 1997 and 2004 were reviewed retrospectively. Age, gender, tumor site, presence of local invasion, depth of tumor invasion, lymph node metastases, stage of the disease, distant metastases, histological differentiation, type of surgery, and blood transfusions were evaluated in relation to survival. Survival curves were estimated using the Kaplan-Meier method and the differences in survival were compared by the log-rank test.
RESULTS: Forty-two cases (34.7%) underwent total gastrectomy, 34 (28.1%) had subtotal gastrectomy, and 45 (37.2%) received palliative surgery. The majority of the patients (61.2%) had stage IV gastric cancer. Total morbidity and mortality were 26.4% and 17.3%, respectively. The factors that influence survival were type of surgery, adjacent organ invasion, existence of metastases, lymph node status, blood transfusions, and stage of the disease in this study. Among the significant prognostic factors in the univariate analysis, only one factor, R0 resection proved to be independently significant in the multivariate analysis.
CONCLUSIONS: R0 resection was found to have a significant favorable effect on survival in our study.

Entities:  

Mesh:

Year:  2007        PMID: 17523337

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

1.  Dissection of No. 13 lymph node in radical gastrectomy for gastric carcinoma.

Authors:  Ding-Feng Shen; Da-Wei Chen; Zhi-Wei Quan; Ping Dong; Xue-Feng Wang; Hai-Zhou Xu; Ming-Lin Zhao; Lei Chen
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

Review 2.  Systematic review of the predictors of positive margins in gastric cancer surgery and the effect on survival.

Authors:  Hamid Reza Raziee; Roberta Cardoso; Rajini Seevaratnam; Alyson Mahar; Lucy Helyer; Calvin Law; Natalie Coburn
Journal:  Gastric Cancer       Date:  2011-12-03       Impact factor: 7.370

3.  Type-specific diagnosis and evaluation of longitudinal tumor extent of borrmann type IV gastric cancer: CT versus gastroscopy.

Authors:  Jung Im Kim; Young Hoon Kim; Kyoung Ho Lee; So Yeon Kim; Yoon Jin Lee; Young Soo Park; Nayoung Kim; Dong Ho Lee; Hyung Ho Kim; Do Joong Park; Hye Seung Lee
Journal:  Korean J Radiol       Date:  2013-07-17       Impact factor: 3.500

4.  Gastric cancer in Turkey-a bridge between west and East.

Authors:  Suayib Yalcin
Journal:  Gastrointest Cancer Res       Date:  2009-01

5.  Phase II Study of Preoperative Intra-Arterial Epirubicin, Etoposide, and Oxaliplatin Combined with Oral S-1 Chemotherapy for the Treatment of Borrmann Type 4 Gastric Cancer.

Authors:  Xiao-Song Xiang; Yu Su; Guo-Li Li; Long Ma; Chang-Sheng Zhou; Ru-Feng Ma
Journal:  J Gastric Cancer       Date:  2020-12-29       Impact factor: 3.720

6.  Peri-operative Outcomes and Survival Following Palliative Gastrectomy for Gastric Cancer: a Systematic Review and Meta-analysis.

Authors:  Joseph Cowling; Bethany Gorman; Afrah Riaz; James R Bundred; Sivesh K Kamarajah; Richard P T Evans; Pritam Singh; Ewen A Griffiths
Journal:  J Gastrointest Cancer       Date:  2020-09-22

7.  Evaluation of Human Epidermal Growth Factor Receptor 2 Overexpression, Clinicopathological Characteristics, and Factors Affecting Survival in Gastric Cancer.

Authors:  Ozde Melisa Celayir; Fatih Selcukbiricik; Canan Tanik; Yuksel Altuntas
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-07-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.